Clinical Outcomes of Rh(D)-Incompatible Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Retrospective Case Series with a Narrative Literature Review
Journal of Blood Medicine · 2026-08 · Volume 17 · 1-8
DOI: 10.2147/jbm.s623234 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Blood Medicine, 2026-08. Verfasst von Miaomiao Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Rh(D)-negative individuals are relatively rare in the Chinese population, and clinical experience with Rh(D)-incompatible allogeneic haematopoietic stem cell transplantation (allo-HSCT) remains limited. Compared with ABO incompatibility, the immunohaematological consequences of Rh(D) mismatch in allo-HSCT are less well defined. Herein, we report a single-centre retrospective case series of four patients receiving Rh(D)-incompatible allo-HSCT at our institution, including two Rh(D)-negative recipients with Rh(D)-positive donors and two Rh(D)-positive recipients with Rh(D)-negative donors. We systematically evaluated post-transplant transfusion strategies, haematological recovery, anti-D alloantibody seroconversion, haemolysis or graft-versus-host disease (GVHD), and long-term survival outcomes. During a median follow-up of 36 months (range, 24-48 months), none of the patients developed detectable anti-D alloantibodies. Only one patient exhibited laboratory evidence of subclinical haemolysis responsive to low-dose prednisone, and another patient developed grade II acute gastrointestinal GVHD controlled by immunosuppressive agents. Nevertheless, all patients achieved sustained haematological engraftment without transplant-related mortalities. Combined with data from a narrative literature review, our single-centre observations are consistent with prior studies showing low risks of clinically significant haemolysis and anti-D alloimmunisation after Rh(D)-incompatible allo-HSCT. Rh(D) mismatch does not appear to be associated with severe transplant complications in our limited cohort, but these findings cannot be generalised broadly given the extremely small sample size. Rigorous peri-transplant transfusion management and regular post-transplant serological monitoring are still mandatory for Rh(D)-mismatched recipients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, People's Republic of China.
- Department of Transfusion Medicine, Changhai Hospital, Shanghai, People's Republic of China.
Zitieren
APA
Liu, M., Lin, M., Fu, W., Wang, Z., Xu, L., Chen, J., Yang, J., Gu, H., & Ni, X. (2026). Clinical Outcomes of Rh(D)-Incompatible Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Retrospective Case Series with a Narrative Literature Review. Journal of Blood Medicine, Volume 17, 1-8. https://doi.org/10.2147/jbm.s623234
Vancouver
Liu M, Lin M, Fu W, Wang Z, Xu L, Chen J, et al. Clinical Outcomes of Rh(D)-Incompatible Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Retrospective Case Series with a Narrative Literature Review. Journal of Blood Medicine. 2026;Volume 17:1-8. doi:10.2147/jbm.s623234
BibTeX
@article{Liu2026,
author = {Liu, Miaomiao and Lin, Min and Fu, Weijia and Wang, Ziwei and Xu, Lili and Chen, Jie and Yang, Jianmin and Gu, Haihui and Ni, Xiong},
title = {Clinical Outcomes of Rh(D)-Incompatible Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Retrospective Case Series with a Narrative Literature Review},
journal = {Journal of Blood Medicine},
year = {2026},
volume = {Volume 17},
pages = {1--8},
doi = {10.2147/jbm.s623234}
}
EUVIMED